2013 ICD-9-CM Diagnosis Code 255.0
- A syndrome characterized by abnormal secretion of adrenocorticotrophic hormone in conjunction with neoplastic growth occurring anywhere in the body. The most common associations are tumors of the bronchus (oat cell or carcinoid), thymic tumors (epithelial or carcinoid), and pancreatic endocrine tumor. (DeVita et al. Cancer, p 1364. 4th edition. Lippincott)
- abnormally increased secretion of adrenal hormones.
- complex of symptoms and signs due to excessive production or administration of hydrocortisone or its semi-synthetic analogs.
- condition, more commonly seen in females, due to hyperadrenocorticism resulting from neoplasms of the adrenal cortex or the anterior lobe of the pituitary, or to prolonged excessive intake of glucocorticoids for therapeutic purposes; symptoms and signs may include rapidly developing adiposity of the face, neck, and trunk, kyphosis caused by osteoporosis of the spine, hypertension, diabetes mellitus, amenorrhea, hypertrichosis in females, impotence in males, dusky complexion with purple markings, polycythemia, pain in the abdomen and back, and muscular wasting and weakness.
- ICD-9-CM 255.0 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
255.0 Alternative Terminology
Convert 255.0 to ICD-10-CM
ICD-9-CM Volume 2 Index entries containing back-references to 255.0: